(Q33967251)

English

A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

based on heuristic

inferred from title

deep vein thrombosis

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1

object named as

H Eriksson

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

K Wåhlander

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D Gustafsson

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L T Welin

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L Frison

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Thrive Investigators

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 January 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

41-47

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871538%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00034.X

21 January 2018

The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00034.X

21 January 2018

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00034.X

21 January 2018

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00034.X

21 January 2018

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00034.X

21 January 2018

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00034.X

21 January 2018

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00034.X

21 January 2018

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00034.X

21 January 2018

Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00034.X

21 January 2018

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00034.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33967251&oldid=1630464294"